Tag: JenaValve

JenaValve Technology appoints John T Kilcoyne as chief executive officer

Medical device executive John T Kilcoyne has been appointed as chief executive officer of JenaValve Technology, effective immediately. In addition, he will serve as...

JenaValve receives FDA approval for expanded IDE enrolment in the treatment...

JenaValve has received US FDA approval of expansion of its investigational device exemption (IDE) feasibility studies for the JenaValve pericardial transcatheter aortic valve implantation...

Patient enrolment in US early feasibility study of Everdur TAVI device...

JenaValve has announced initiation of patient enrolment in its early feasibility study (EFS) of its next-generation JenaValve pericardial transcatheter aortic valve implantation (TAVI) system...

Implantation of JenaValve successful in initial patients enrolled in CE mark...

JenaValve Technology has announced the initiation of patient enrolment and implantations associated with the CE mark study of its next-generation JenaValve pericardial transcatheter aortic...

Study of next-generation JenaValve device completes enrolment

A press release reports that successful patient enrolment in the CE mark study of the next-generation JenaValve pericardial transcatheter aortic valve implantation (TAVI) system—using...